Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 08, 2019

SELL
$29.93 - $36.8 $237,644 - $292,192
-7,940 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$27.65 - $31.68 $82 - $95
3 Added 0.04%
7,940 $252,000
Q1 2019

May 13, 2019

BUY
$26.79 - $31.72 $160 - $190
6 Added 0.08%
7,937 $237,000
Q4 2018

Feb 13, 2019

BUY
$29.28 - $41.29 $644 - $908
22 Added 0.28%
7,931 $245,000
Q3 2018

Nov 06, 2018

SELL
$34.44 - $39.35 $7,576 - $8,657
-220 Reduced 2.71%
7,909 $300,000
Q2 2018

Aug 10, 2018

BUY
$28.49 - $38.41 $1,737 - $2,343
61 Added 0.76%
8,129 $312,000
Q1 2018

May 07, 2018

BUY
$32.94 - $46.03 $2,141 - $2,991
65 Added 0.81%
8,068 $272,000
Q4 2017

Feb 06, 2018

BUY
$40.63 - $50.91 $61,432 - $76,975
1,512 Added 23.29%
8,003 $355,000
Q3 2017

Nov 08, 2017

BUY
$48.69 - $53.63 $316,046 - $348,112
6,491
6,491 $325,000

Others Institutions Holding PBH

About Prestige Consumer Healthcare Inc.


  • Ticker PBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,762,600
  • Market Cap $3.68B
  • Description
  • Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...
More about PBH
Track This Portfolio

Track Ing Groep Nv Portfolio

Follow Ing Groep Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.